Patient preference information
Patient preference information (PPI) refers to assessments of the relative desirability or acceptability to patients of specified alternatives or choices among outcomes or other attributes that differ among alternative health interventions. The methods for generating PPI may be qualitative, quantitative, or mixed methods.
U.S. Food and Drug Administration (FDA) Patient-Focused Drug Development Glossary
U.S. Food and Drug Administration (FDA): Patient Preference-Sensitive Areas – Using Patient Preference Information in Medical Device Evaluation
NCATS Toolkit for Patient-Focused Therapy Development: Perform Patient Preference Studies
U.S. Food and Drug Administration (FDA): Patient Preference Information – Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling